Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
27.8M
-
Number of holders
-
93
-
Total 13F shares, excl. options
-
13.6M
-
Shares change
-
-290K
-
Total reported value, excl. options
-
$196M
-
Value change
-
-$4.16M
-
Put/Call ratio
-
1.71
-
Number of buys
-
41
-
Number of sells
-
-38
-
Price
-
$14.39
Significant Holders of Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) as of Q2 2016
109 filings reported holding AXDX - Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share as of Q2 2016.
Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) has 93 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.6M shares
of 27.8M outstanding shares and own 48.77% of the company stock.
Largest 10 shareholders include Birchview Capital, LP (2.18M shares), VANGUARD GROUP INC (1.09M shares), CANNELL PETER B & CO INC (1.05M shares), FIRST REPUBLIC INVESTMENT MANAGEMENT, INC. (757K shares), Nuveen Asset Management, LLC (711K shares), Miura Global Management, LLC (700K shares), BlackRock Institutional Trust Company, N.A. (631K shares), Arrowpoint Asset Management, LLC (619K shares), BlackRock Fund Advisors (549K shares), and WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (467K shares).
This table shows the top 93 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.